Categories
Loading...
Categories
Valiant Laboratories has announced a board meeting to discuss and confirm the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the quarter ended March 31, 2025. The company has received confirmation from its Registrar and Share Transfer Agent, MUFG Intime India Pvt. Ltd., regarding the status of securities for dematerialisation. Notably, there were no demat/remat requests processed during this quarter. This assurance on compliance may bolster investor confidence, highlighting the company's commitment to regulatory adherence and operational integrity. Overall, it suggests a neutral impact on investor sentiment, keeping operational transparency in focus.